======= FICD =======
== Gene Information ==
* **Official Symbol**: FICD
* **Official Name**: FIC domain protein adenylyltransferase
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=11153|11153]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9BVA6|Q9BVA6]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=FICD&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20FICD|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/620875|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Protein that can both mediate the addition of adenosine 5'-monophosphate (AMP) to specific residues of target proteins (AMPylation), and the removal of the same modification from target proteins (de-AMPylation), depending on the context (By similarity). The side chain of Glu-231 determines which of the two opposing activities (AMPylase or de-AMPylase) will take place (By similarity). Acts as a key regulator of the ERN1/IRE1-mediated unfolded protein response (UPR) by mediating AMPylation or de- AMPylation of HSPA5/BiP (PubMed:25601083). In unstressed cells, acts as an adenylyltransferase by mediating AMPylation of HSPA5/BiP at 'Thr-518', thereby inactivating it (By similarity). In response to endoplasmic reticulum stress, acts as a phosphodiesterase by mediating removal of ATP (de-AMPylation) from HSPA5/BiP at 'Thr-518', leading to restore HSPA5/BiP activity (By similarity). Although it is able to AMPylate RhoA, Rac and Cdc42 Rho GTPases in vitro, Rho GTPases do not constitute physiological substrates (PubMed:19362538, PubMed:25601083). {ECO:0000250|UniProtKB:A0A061I403, ECO:0000269|PubMed:22266942, ECO:0000269|PubMed:25435325, ECO:0000269|PubMed:25601083, ECO:0000305|PubMed:19362538}.
|Fic|
|protein denucleotidylation|
|protein adenylylhydrolase activity|
|protein deadenylylation|
|protein adenylylation|
|protein nucleotidylation|
|protein adenylyltransferase activity|
|regulation of IRE1-mediated unfolded protein response|
|regulation of endoplasmic reticulum unfolded protein response|
|Hsp70 protein binding|
|negative regulation of GTPase activity|
|regulation of response to endoplasmic reticulum stress|
|chaperone binding|
|integral component of endoplasmic reticulum membrane|
|response to unfolded protein|
|response to topologically incorrect protein|
|response to endoplasmic reticulum stress|
|negative regulation of hydrolase activity|
|regulation of GTPase activity|
|regulation of cellular response to stress|
|negative regulation of catalytic activity|
|protein homodimerization activity|
|identical protein binding|
|negative regulation of molecular function|
|regulation of hydrolase activity|
|regulation of response to stress|
|ATP binding|
|cellular response to stress|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp538|ZLN024 50μM R08 exp538]]|-1.78|
|[[:results:exp319|ABT-702 5μM plus Dimethyloxaloylglycine 11μM R07 exp319]]|1.72|
|[[:results:exp49|NFN1 0.1μM R01 exp49]]|1.9|
|[[:results:exp47|Lapatinib 5μM R01 exp47]]|1.95|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 11321
* **Expression level (log2 read counts)**: 3.03
{{:chemogenomics:nalm6 dist.png?nolink |}}